Bella Czajkowski
- Indexed articles, last 90 days
- 24
- Latest publication
- Sep 29, 2026
- Outlet visibility, for MM+M - Medical Marketing and Media
- Top 5M sites
- Earliest in this view
- Jul 6, 2026
Latest articles
120/80 Health Group restructures in response to evolving business demands (opens the original)
Read excerpt
120/80 Health Group is reshaping its business structure around a broader ambition of becoming less of a traditional communications firm and more of a strategic partner to healthcare and life sciences companies navigating how to bring new products and technologies to market. On Tuesday, the company formally unveiled 120/80 Health Group as its enterprise identity alongside a series of leadership changes. CEO Rob Cronin said the eight-year-old firm has continued to grow its client roster, adding wo
Skyrizi holds pharma TV lead in August, while Colgate tops YouTube rankings (opens the original)
Read excerpt
AbbVie’s Skyrizi retained the top spot in pharma’s national TV rankings in August, while Colgate led health brands on YouTube with 160 million views, according to the latest data from iSpot and Tubular Labs. Skyrizi generated 2.8 billion national TV ad impressions during the month, accounting for a 4.9% share of voice (SOV). The brand spent an estimated $30.4 million on national TV advertising, with ABC delivering the greatest share of its impressions and Forensic Files ranking as its top progra
What Cologuard Plusâ telenovela campaign teaches marketers about reaching Hispanic audiences (opens the original)
Read excerpt
Colorectal cancer screening can be an uncomfortable topic in any language. For Cologuard Plus, making that conversation more approachable for Hispanic audiences meant turning to a familiar storytelling format: the heightened drama and humor of telenovelas. The new Spanish-language campaign also offers a broader lesson for healthcare marketers during Hispanic Heritage Month. Reaching Hispanic consumers requires more than translating an English-language advertisement into Spanish. Instead, context
Former VA secretary Dr. David Shulkin tells pharma how to navigate Trumpâs dealmaking approach (opens the original)
Read excerpt
President Donald Trump’s approach to pharmaceutical policy can appear unpredictable, but former Veterans Affairs Secretary Dr. David Shulkin believes drugmakers can find a pattern in the noise. Speaking Tuesday at the Indegene Digital Summit in Philadelphia, Shulkin described an administration that begins negotiations with aggressive demands, moves quickly and expects industry leaders to respond in the room. For pharmaceutical executives, he said, the lesson is to arrive prepared to make a deal.
Ardelyx puts lessons from FDAâs Untitled Letters into practice in first Ibsrela TV campaign (opens the original)
Read excerpt
If the FDA’s recent flurry of Untitled Letters offered the pharmaceutical industry a test, Ardelyx studied for it. The drugmaker debuted “Because Ibsrela Can,” its first connected TV advertising campaign for the drug, with a creative approach shaped in part by the FDA’s objections to other pharma promotions over the past year. Accenture’s SongLife led the campaign’s creative development, and CMI Media Group is leading media strategy, planning and placement. In the commercial, patients with irrit
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For MM+M - Medical Marketing and Media, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.